Lisdexamfetamine dimesylate

Amber

Brand Name(s):Elvanse

Indication:ADHD in children aged 6 years of age and over when response to previous methylphenidate treatment is considered clinically inadequate.

Rationale:

Considered:Jul-13

Review Date:Jul-23

Comments:
NICE NG87
Attention deficit hyperactivity disorder: diagnosis and management
Mar-18